Company History

GliaPharm is a Swiss biotechnology company that develops innovative approaches to treat neurological and psychiatric disorders. GliaPharm was created in 2016 as a spinoff company of three decades of research performed in the laboratory of Prof. Pierre Magistretti at Ecole Polytechnique Fédérale de Lausanne (EPFL, Switzerland), a leading research laboratory in the field of brain metabolism and glial cell biology.

In 2017, GliaPharm has established its laboratory at the Campus Biotech in Geneva, Switzerland.

Through its in-house R&D laboratory and network with selective partners, GliaPharm provides the necessary platform to develop clinical applications arising from the know-how and fundamental discoveries accumulated throughout three decades of research in the academic setting.